Experience:
2023 -
Medipol Bahçelievler
2017 - 2023
Özel İstinye Üniv. Gaziosmanpaşa Medical Park Hopspital
2015 - 2017
DPÜ Evliya Çelebi Eğitim ve Araştırma Hastanesi
2012 - 2015
Süleyman Demirel Üniversitesi Tıp Fakültesi
2008 - 2011
Kırıkkale Devlet Hastanesi
2007 - 2007
Elazığ Eğitim ve Araştırma Hastanesi
2007 - 2008
Eskişehir Asker Hastanesi
2005 - 2007
Elazığ Karakoçan Devlet Hastanesi
2001 - 2001
Batman Beşiri İkiköprü Sağlık Ocağı
2001 - 2005
Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı
Education:
2015
Süleyman Demirel University Faculty of Medicine, Nephrology
2005
Dicle University Faculty of Medicine, Internal Medicine
2000
Ege University, Faculty of Medicine
Title: Prospective Surveillance Study For Risk Factors Of Central Venous Catheter-Related Bloodstream Infections.
Title: Serum C-Reactive Protein (CRP) Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovarian Syndrome, And Effect Of Bicalutamide On Hirsutism, CRP Levels And Insulin Resistance.
Title: Spontaneous Rupture Of The Spleen In A Hemodialysis Patient.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Fenofibrate Treatment In Two Adults With Crigler-Najjar Syndrome Type II.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Title: The Relationship Between Serum C-Reactive Protein Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovary Syndrome.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Experience:
2023 -
Medipol Bahçelievler
2017 - 2023
Özel İstinye Üniv. Gaziosmanpaşa Medical Park Hopspital
2015 - 2017
DPÜ Evliya Çelebi Eğitim ve Araştırma Hastanesi
2012 - 2015
Süleyman Demirel Üniversitesi Tıp Fakültesi
2008 - 2011
Kırıkkale Devlet Hastanesi
2007 - 2007
Elazığ Eğitim ve Araştırma Hastanesi
2007 - 2008
Eskişehir Asker Hastanesi
2005 - 2007
Elazığ Karakoçan Devlet Hastanesi
2001 - 2001
Batman Beşiri İkiköprü Sağlık Ocağı
2001 - 2005
Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı
Education:
2015
Süleyman Demirel University Faculty of Medicine, Nephrology
2005
Dicle University Faculty of Medicine, Internal Medicine
2000
Ege University, Faculty of Medicine
Title: Prospective Surveillance Study For Risk Factors Of Central Venous Catheter-Related Bloodstream Infections.
Title: Serum C-Reactive Protein (CRP) Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovarian Syndrome, And Effect Of Bicalutamide On Hirsutism, CRP Levels And Insulin Resistance.
Title: Spontaneous Rupture Of The Spleen In A Hemodialysis Patient.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Fenofibrate Treatment In Two Adults With Crigler-Najjar Syndrome Type II.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Title: The Relationship Between Serum C-Reactive Protein Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovary Syndrome.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
| Visite du médecin | prix sur demande |
| Dialyse | $200 |
| Néphrectomie | $8000 - $12000 |
After receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).
Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.
Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.
With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.
Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).
Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.
Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:
After receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).
Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.
Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.
With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.
Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).
Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.
Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:
Le Dr Mehdi Afrit est un oncologue médical qui exerce à l'hôpital spécialisé Burjeel de Sharjah. Il possède plus de 11 ans d’expérience dans le soin et la gestion de patients atteints de cancer. Il possède une vaste expérience dans la chimiothérapie, l’hormonothérapie, l’immunothérapie et la thérapie ciblée pour les patients. Il a obtenu un certificat d'oncologie médicale de l'Institut Gustave Roussy à Paris, en France, où il a suivi une formation en chimiothérapie antitumorale et en traitement médical du cancer. De plus, il est titulaire d'un certificat international en maladies du sein. Il possède également un certificat en bonnes pratiques cliniques de Trans Celerate Biopharma Inc. et un certificat en gestion des essais cliniques : bonnes pratiques cliniques de la Faculté de médecine pharmaceutique du Collège royal des médecins. Il a auparavant travaillé pendant plus de cinq ans comme professeur adjoint d'oncologie médicale à la Faculté de médecine de Tunis. Il a ensuite exercé comme consultant, oncologue médical pendant six ans à l'hôpital Arianna en Tunisie. Il a ensuite travaillé pendant deux ans comme oncologue médical spécialisé à l'hôpital Zulekha. Il a également été chercheur dans trois essais cliniques internationaux et détient des certifications d'audit d'essais cliniques, de CRO et un certificat de formation GCP de 2016. Il est membre en règle de l'Emirates Oncology Society (EOS), de la Société européenne d'oncologie médicale (ESMO). ) et l'American Society of Clinical Oncology (ASCO). Son expertise clinique comprend, sans s'y limiter, les éléments suivants :
Le Dr Mehdi Afrit est un oncologue médical qui exerce à l'hôpital spécialisé Burjeel de Sharjah. Il possède plus de 11 ans d’expérience dans le soin et la gestion de patients atteints de cancer. Il possède une vaste expérience dans la chimiothérapie, l’hormonothérapie, l’immunothérapie et la thérapie ciblée pour les patients. Il a obtenu un certificat d'oncologie médicale de l'Institut Gustave Roussy à Paris, en France, où il a suivi une formation en chimiothérapie antitumorale et en traitement médical du cancer. De plus, il est titulaire d'un certificat international en maladies du sein. Il possède également un certificat en bonnes pratiques cliniques de Trans Celerate Biopharma Inc. et un certificat en gestion des essais cliniques : bonnes pratiques cliniques de la Faculté de médecine pharmaceutique du Collège royal des médecins. Il a auparavant travaillé pendant plus de cinq ans comme professeur adjoint d'oncologie médicale à la Faculté de médecine de Tunis. Il a ensuite exercé comme consultant, oncologue médical pendant six ans à l'hôpital Arianna en Tunisie. Il a ensuite travaillé pendant deux ans comme oncologue médical spécialisé à l'hôpital Zulekha. Il a également été chercheur dans trois essais cliniques internationaux et détient des certifications d'audit d'essais cliniques, de CRO et un certificat de formation GCP de 2016. Il est membre en règle de l'Emirates Oncology Society (EOS), de la Société européenne d'oncologie médicale (ESMO). ) et l'American Society of Clinical Oncology (ASCO). Son expertise clinique comprend, sans s'y limiter, les éléments suivants :
Néphrologue, spécialiste en transplantation rénale
Lire la suiteNéphrologue, spécialiste en transplantation rénale
Le Dr Chetan Prakash est un chirurgien orthopédique spécialisé, titulaire d'un MBBS, d'un D-Ortho et d'un DNB (Ortho). Il a une grande expérience des prothèses de hanche et de genou, de la chirurgie de révision, du resurfaçage de la hanche et d'autres chirurgies orthopédiques. Il a obtenu une bourse en chirurgie orthopédique et en traumatologie sportive à l'hôpital Kanto Bruderholz de Bâle, en Suisse. Le Dr Prakash parle anglais, arabe et hindi et s'intéresse particulièrement aux blessures sportives, au fixateur externe d'Ilizarov, aux clous à emboîtement et à l'arthroplastie de la hanche et du genou. Il a publié sa thèse de recherche sur l'allongement des membres dans des revues internationales.
Lire la suiteLe Dr Chetan Prakash est un chirurgien orthopédique spécialisé, titulaire d'un MBBS, d'un D-Ortho et d'un DNB (Ortho). Il a une grande expérience des prothèses de hanche et de genou, de la chirurgie de révision, du resurfaçage de la hanche et d'autres chirurgies orthopédiques. Il a obtenu une bourse en chirurgie orthopédique et en traumatologie sportive à l'hôpital Kanto Bruderholz de Bâle, en Suisse. Le Dr Prakash parle anglais, arabe et hindi et s'intéresse particulièrement aux blessures sportives, au fixateur externe d'Ilizarov, aux clous à emboîtement et à l'arthroplastie de la hanche et du genou. Il a publié sa thèse de recherche sur l'allongement des membres dans des revues internationales.